All Tox In Focus volumes
Tox In Focus
|
Focused Clinical Reference
Vol. 11  ·  Specimen Validity Testing  ·  July 2026
SPECIMEN VALIDITY TESTING
Confirming a urine sample is real, concentrated, and unadulterated before you trust the result

Specimen validity testing (SVT) checks whether a urine sample is genuine, adequately concentrated, and free of adulterants before its drug results are trusted. Dilution, substitution, and adulteration can all push a true positive below the cutoff, so an invalid specimen can make a patient who is using drugs appear negative.1

Why This Matters Now

When high-volume drug testing expanded in the 1990s, dilute samples reported as negative were shown to contain drugs below the cutoff at much higher rates than normal samples, which led federal programs to mandate SVT and standardize its methods.1 Adulterant products such as nitrite, PCC, glutaraldehyde, and peroxide remain marketed online and in shops to defeat testing.2

⚠ An abnormal SVT result with an inconsistent drug result may warrant a new collection, an observed or oral-fluid collection, or more frequent testing; abnormal SVT alone does not prove intent.
Interpreting Abnormal Results
DILUTION / SUBSTITUTION
Dilute: creatinine <20 mg/dL and SG <1.003
Very low creatinine (<2 mg/dL): not human urine
SG <1.001 or >1.020 with low creatinine: substitution
Clear color; abnormal temperature at collection
Low creatinine can also reflect low muscle mass or renal disease
ADULTERATION
High oxidant activity (nitrite, PCC, bleach, peroxide)
Abnormal pH (very high or very low)
Unusual color, odor, or foreign objects
Oxidants can degrade cannabinoids and affect opiates
Glutaraldehyde disrupts immunoassay without removing drug
Important: Abnormal SVT does not always indicate tampering. Urinary tract infection or blood can raise oxidant near 200 mcg/mL, pH can rise to 9.5 with storage, and low muscle mass lowers creatinine. Interpret with the clinical picture.
Additional Clinical Uses

Beyond confirming integrity, SVT supports interpretation. Urinary pH affects excretion of drugs such as methadone, phenobarbital, and amphetamines, so pH shifts can explain fluctuating urinary levels. Creatinine can normalize a patient's drug and metabolite concentrations across serial samples to compare results over time.3 Routine SVT may not detect all synthetic urines.4

Clinical Guidance
  • Order SVT with every urine drug test to assess integrity and aid interpretation.
  • Read the four measures together: creatinine and specific gravity for dilution or substitution, oxidant and pH for adulteration.
  • Treat creatinine <2 mg/dL as not physiologically possible; the sample is not human urine.
  • Do not act on an abnormal SVT in isolation; correlate with observed collection, temperature, and clinical context.
  • Use creatinine normalization to distinguish new use from residual excretion in serial monitoring.3
Point-of-Care Testing Availability
Available strips
Point-of-care validity dipsticks screen creatinine, specific gravity, pH, and oxidants.
Clinical use
Useful at collection to flag dilute or tampered samples immediately.
Limitations
Confirm abnormal results with laboratory SVT; dipsticks may miss some synthetic urines.
SPECIMEN VALIDITY TESTING  |  Clinical & Program Guidance
Tox In Focus Vol. 11  ·  July 2026  ·  Page 2 of 2
Validity Markers and Causes of an Abnormal Result
Validity MarkerWhat Can Cause an Abnormal Result
Creatinine
>20 mg/dL
Dilution: excessive fluid intake near collection (~3 quarts within hours, especially with a diuretic); water added to the specimen. Substitution: very low (<2 mg/dL) or absent creatinine is not physiologically possible; the specimen is not human urine. Benign: low muscle mass; renal disease; elevated storage temperature can lower measured creatinine, mimicking dilution.
Specific Gravity
1.003–1.035
Dilution: <1.003 with low creatinine (over-hydration or added water); <1.001 approximates water. Adulteration: added salt (sodium chloride) raises specific gravity and can cause false-negative immunoassay. Substitution: >1.020 with low creatinine suggests a non-urine liquid (e.g., juice). Benign: high specific gravity with elevated creatinine is concentrated urine from dehydration.
Oxidant
<200 mcg/mL
Adulteration: nitrites (Klear, Whizzies), PCC (Urine Luck), chromium(VI), bleach and other halogens, peroxide (Stealth), glutaraldehyde (Urine Aid). Benign / other: urinary tract infection (values near 200 mcg/mL); blood contamination; dietary nitrite (cured meats; celery, spinach, beets); nitrate-rich well water; nitrate medications.
pH
4.5–9.5
Adulteration: acidic or alkaline adulterants (abnormally high or low pH). Benign (acidic): uncontrolled diabetes or DKA, ketogenic or high-protein diet, SGLT2 inhibitors, systemic acidosis. Benign (alkaline): natural rise toward 9.5 with prolonged storage.

Markers are interpreted as a whole, alongside the laboratory's physical examination (color, odor, foreign objects) and specimen temperature at collection. No single marker confirms tampering on its own. Some adulterants, such as surfactants and detergents, are not reliably detected by these four tests and may require a dedicated assay or direct observation.

Key References
  1. Cone EJ, Lange R, Darwin WD. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results. J Anal Toxicol. 1998;22:460-473.
  2. Jaffee WB, et al. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abuse Treat. 2007;33:33-42.
  3. Cone EJ, et al. Normalization of urinary drug concentrations with specific gravity and creatinine. J Anal Toxicol. 2009;33(1):1-7.
  4. Goggin MM, et al. Catching fakes: new markers of urine sample validity and invalidity. J Anal Toxicol. 2017;41:121-126.
DISCLAIMER: This document is intended for clinical reference and educational purposes only. It does not constitute medical, legal, or professional advice and should not replace independent clinical or programmatic judgment. Content reflects published data available at time of preparation. ToxiPharm LLC makes no warranties regarding completeness or applicability in all settings.  |   © 2026 ToxiPharm LLC  |  toxipharm.org
Back to Tox In Focus ToxiPharm home →